AAN 2022: Study Identifies Early Predictors of Disability in Pediatric-Onset Multiple Sclerosis
Persistent use of high-efficacy disease modifying therapies was associated with a lower risk of disability
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.